Internal Medicine, Cardiovascular Disease · Wellington, FL
NPI
1790969137
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
8440 Lake Worth Rd Ste 100
Wellington, FL, 33467
Phone (561) 967-5033
Groups this clinician bills Medicare through
Medicare paid, 2024
$402K
5,833 services
Medicare patients, 2024
1,842
Average age 77
Drug cost, 2024
$1.7M
6,432 prescriptions
Company payments, 2025
$1,200
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nagavardhan Vasuki was code 93010 (electrocardiogram), 1,155 times for 971 patients. In total Nagavardhan Vasuki billed 5,833 services in 51 codes, and Medicare paid $402K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 1,155 | 971 | $6.43 | $7,425 |
| 99214 Office E&M - Established | Office | 727 | 371 | $92.37 | $67K |
| 99233 Hospital E&M - Subsequent | Facility | 562 | 285 | $93.49 | $53K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 547 | 341 | $12.56 | $6,870 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 376 | 94 | $5.46 | $2,053 |
| 93306 Echocardiography (TTE/TEE) | Office | 351 | 342 | $143.77 | $50K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 304 | 152 | $174.64 | $53K |
| 93000 Electrocardiogram | Office | 289 | 278 | $10.72 | $3,099 |
| 93306 Echocardiography (TTE/TEE) | Facility | 202 | 201 | $52.03 | $11K |
| 99223 Hospital E&M - Initial | Facility | 158 | 155 | $136.11 | $22K |
| 78452 Myocardial Perfusion Scan | Office | 152 | 152 | $336.43 | $51K |
| 93015 Electrocardiogram | Office | 147 | 147 | $49.14 | $7,224 |
| 99204 Office E&M - New | Office | 109 | 109 | $116.41 | $13K |
| 93296 External Electrocardiographic Monitoring | Office | 105 | 38 | $16.54 | $1,736 |
| 93294 External Electrocardiographic Monitoring | Office | 89 | 32 | $23.23 | $2,067 |
By year: 2022 $455K for 4,889 services; 2023 $421K for 5,414 services; 2024 $402K for 5,833 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nagavardhan Vasuki prescribed most often to Medicare patients was Eliquis (Apixaban), with 627 prescriptions and refills. In total Nagavardhan Vasuki wrote 6,432 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 627 | 1,087 | 166 | $621K |
| Metoprolol Succinate Generic | 584 | 1,643 | 199 | $7,422 |
| Atorvastatin Calcium Generic | 377 | 1,074 | 122 | $3,337 |
| Rosuvastatin Calcium Generic | 374 | 1,066 | 132 | $3,429 |
| Amlodipine Besylate Generic | 307 | 875 | 108 | $1,366 |
| Losartan Potassium Generic | 235 | 663 | 81 | $1,873 |
| Carvedilol Generic | 232 | 614 | 66 | $1,409 |
| Ezetimibe Generic | 199 | 530 | 65 | $3,867 |
| Repatha Sureclick Evolocumab | 198 | 275 | 40 | $157K |
| Xarelto Rivaroxaban | 198 | 351 | 49 | $190K |
| Spironolactone Generic | 194 | 520 | 66 | $1,400 |
| Lisinopril Generic | 188 | 520 | 65 | $945 |
| Clopidogrel Clopidogrel Bisulfate | 181 | 499 | 58 | $1,877 |
| Hydralazine Hcl Generic | 163 | 401 | 54 | $2,134 |
| Nexlizet Bempedoic Acid/Ezetimibe | 146 | 293 | 42 | $116K |
Brand drugs: 1,777 claims; generic drugs: 4,655 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nagavardhan Vasuki $1,200 ($1,200 in general payments such as food, travel and fees) from 16 companies. The largest payer was Novartis Pharmaceuticals Corporation with $418.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 21 | $418 |
| Amgen Inc. AMGN | 15 | $179 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $140 |
| Medtronic, Inc. MDT | 1 | $76.59 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $54.4 |
| Kestra Medical Technology Services, Inc. | 1 | $51.13 |
| Merck Sharp & Dohme LLC MRK | 2 | $50.79 |
| CVRx, Inc. CVRX | 2 | $44.66 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $40.45 |
| Heartflow, Inc. HTFL | 1 | $30.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.